Speakers

Ruben Abagyan, PhD

Professor

University of California, San Diego

Jonathan Abysalh

Sr. Director, US Section Head Process Development

Sanofi

Daniel Ahlstedt

Chief Operating Officer and Co-Founder

EnPlusOne Bio

Seth Alexander, PhD

Director of RNA Technologies

Prime Medicine

Rachael Anatol

Deputy Super Office Director, Office of Therapeutic Products, CBER

FDA

Firoz Antia, PhD

Vice President, Oligonucleotide & Small Molecule CMC

Denali Therapeutics

Lilit Avagyan

Team Leader Customized Solutions

Knauer

Raman Bahal, PhD

Associate Professor, Department of Pharmaceutical

University of Connecticut

Kerry Benenato, PhD

Chief Platform Officer

Sail Biomedicines

Arne Berthelmann

Senior Director Oligonucleotide R&D

Bachem AG

Brandon Bock

Associate Director, Analytical Development/QC

Ionis Pharmaceuticals

Melissa Bonner, PhD

Chief Scientific Officer

nChroma Bio

Dr. Roland Bottger, PhD

Senior Research Scientist

CureVac SE

Luis Brito, PhD

Vice President, Delivery Platform

Beam Therapeutics

Joshua Brooks, PhD

Director, Process Sciences

Alnylam Pharmaceuticals

Michael Byrne, PhD

VP, Research Pharmacology

Wave Life Sciences

Ms Melanie Cerullo

Cheif Quality and Regulatory Officer

ReciBioPharm

Chris Chorley

Associate Director, Regulatory Affairs CMC

Biogen

Dana Chreng

Director, Manufacturing & Operations

Ionis

Michelle Colgrave, PhD

Professor of Food & Agricultural Proteomics

Edith Cowan University

Jon Cooper, PhD

Vice President – mRNA Sciences and Analytical Development

Aldevron

Dr. David Corey, PhD

Professor of Pharmacology and Biochemistry

UT Southwestern; Past President, OTS

Cecilia Cotta-Ramusino, PhD

Senior Vice President – Head of Platform

Tessera Therapeutics

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Nadia Cumbal

Principal Scientist

Intellia Therapeutics

Daniel DeOliveira, PhD

Vice President, Drug Substance Development and Manufacturing

Kailera Therapeutics

Frank DeRosa, PhD

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence

Sanofi

Stephen Dietrich

Associate Director, RNA Process Development

Sarepta Therapeutics

Steven Dowdy

Professor

UCSD School of Medicine, USA

Wayne Doyle

Head of Platform

Eclipse Bioinnovations

Jeremy Duffield, MD, PhD, FRCP

Chief Scientific Officer

Prime Medicine

Ralf Eisenhuth, PhD

Principal Scientist

Bachem AG

Eric Fang, PhD

General Manager and Site Head

Snapdragon Chemistry, a Cambrex Company

Shiyue Fang, PhD

Professor

Michigan Technological University

Hadi Fares, PhD

Senior Scientist

DuPont Water Solutions

Gregory Farlow

Senior Oligonucleotide Product Sales Specialist

Cytiva

Cecilia Fernández, Ph.D.

Entrepreneur in Residence

Mass General Brigham Ventures

Mike Flanagan, PhD

Chief Scientific Officer

Avidity Biosciences

Stephanie Forget, PhD

Senior Scientist, Protein Engineering

Codexis

Brendan Frey, PhD

Founder and Chief Innovation Officer

Deep Genomics

Doug Fuerst

Executive Director

GSK

Dave Garman, PhD

VP of Translation and Development

ProteinQure

Andrew Geall, PhD

Co-founder and Chief Development Officer

Replicate Bioscience

Martin Gilar, PhD

Research Fellow

Waters Corporation

Rebecca Goldman, PhD

Associate Director, Formulations

Tessera Therapeutics

Tyler Goodwin, PhD

Head of Delivery Technologies

Tune Therapeutics

Chris Gothard, PhD

Director of Technical Marketing and Communications

CPC Scientific

Andreas Goutopoulos, PhD

CEO and Co-founder

Actithera

Alexandre Goyon, Ph.D

Principal Scientist

Genentech

Robert Gronke, PhD

Senior Principal Scientist

Biogen, Inc

Stephen Groskreutz, PhD

Senior Director of Analytical Development in Bioproduct Research and Development

Eli Lilly and Company

Joe Guiles, PhD

Head of Chemical Development, Nucleic Acids Solution Division

Agilent Technologies

Sonia Henriques

Associate Professor in Biochemistry

The University of Queensland

Roman Hillebrand, Ph.D.

Associate Director of Manufacturing Innovation

Arrowhead Pharmaceuticals

Cory Hinz

Engineering Manager

Asahi Kasei Bioprocess

Elissa Hobert, PhD

Director of Discovery Technologies

NewCo

Marcel Hollenstein, PhD

Head of Research Unit

Institut Pasteur

Dr. Cindy Hong, PhD

Associate Principal Scientist in Biocatalysis, Process Chemistry

Merck

Sunhee Hwang, PhD

Scientist 4

Genentech

Aimee Jackson, PhD

Chief Scientific Officer

Atalanta Therapeutics

Marc Jacob, PhD

Executive Director of Business Development

SK pharmteco

Guillaume Jacquot, PhD

Program Director, Brain and Tissue Delivery of Oligonucleotides

Vect-Horus

Martin Johnson, PhD

Vice President, Engineering

Eli Lilly

Joshua Jones, PhD

Advisor - Analytical Chemistry - SMDD

Eli Lilly and Company

Priya Karmali, PhD

Chief Technology Officer

Capstan Therapeutics

Dr Jens Kaufmann, PhD

Director Technical Operations

3B Pharmaceuticals

Miriam Kidron

Chief Scientific Officer and Director

Oramed Pharmaceuticals Inc.

Dr. Lotte Bjerre Knudsen, PhD

Chief Scientific Advisor & Head of GLP-1 CoE

Novo Nordisk A/S

Troels Koch, PhD

Chief Technology Officer

MiNa Therapeutics

Caroline Kohrer, PhD

Senior Vice President, Discovery Platform

Alltrna

Michael Kopach, PhD

Associate Vice President

Eli Lilly and Company

Holly Kordasiewicz, PhD

SVP Research, Franchise Leader Neurology R&D

Ionis Pharmaceuticals

Peter Korytko, Ph.D.

President

Preclinical GPS

Andreas Kuhn, PhD

Senior Vice President RNA Biochemistry & CMC Development

BioNTech SE

Jayesh Kulkarni

Co-Founder & Chief Scientific Officer

NanoVation Therapeutics

Dr. Joseph Kupferman, PhD

Senior Director, Clinical Development

Moderna

Frederic Lamaty, Ph.D.

Director of Research, Head of Green Chemistry Team

University of Montpellier

Nicole Lawrence, PhD

Senior Research Fellow

Institute for Molecular Bioscience and Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland

Dr. Martin Leuthold, PhD

Head of PD Filtration and Chromatography Consumables

Sartorius

Art Levin, PhD

Retired CSO

Avidity Biosciences

Susan Li, PhD

Peptide Chief Scientist

Asymchem

Dr. Zifan Li, PhD

Senior Scientist

Biogen

Suiyang Liao, PhD

Postdoctoral Research Fellow

University of British Columbia

Jory Lietard

Associate Professor

University of Vienna

Karsten Lindhardt, MSc, PhD, DBE

CEO

Biograil

Ewa Lis, PhD

Founder and CEO

Koliber Biosciences

Troy Lister

Chief Scientific Officer

Verve Therapeutics

Fa Liu, PhD

Chief Scientific Officer

Full-Life Technologies

Olivier Ludemann-Hombourger, PhD

Director, Global Innovation and Technology

PolyPeptide Group

Mabrouka Maamra

Project Manager

University of Sheffield

Harris Makatsoris

Academics Professor of Sustainable Manufacturing Systems

King's College London

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Innovation and Distinguished Research Scientist

Alnylam Pharmaceuticals

Jennifer Martin

Senior Advisor, ADME

Eli Lilly and Company

Scott May, PhD

VP Chemistry - Genetic Medicine

Eli Lilly and Company

Dr Shila Mekhoubad, PhD

Senior Director, Biology

Trace Neuroscience

Laurin Melzig, PhD

Director R&D Process Development

Bachem AG

Dr. Michael Mingueneau, PhD

Head of Immunology

Sail Biomedicines

Takuya Miyagawa

Research Associate

Sumitomo Chemical Co., Ltd.

Alison Moore

Chief Technical Officer

Codexis

Bruce Morimoto, PhD

Drug Development Advisor

Alto Neuroscience

Dr. Tyson Moyer, PhD

Principal Scientist

Korro Bio

Laura Muehlbauer, PhD

Advisor

Eli Lilly and Company

Dr. Subha Mukherjee, PhD

Scientific Director, Synthetic Molecule Design and Development

Eli Lilly and Company

Swagatam Mukhopadhyay, PhD

Co-founder & Chief Scientific Officer

Creyon Bio

Gary Musso, PhD

President

Musso and Associates LLC

Jayaprakash Nair, PhD

Vice President, Research, Chemistry and Delivery Science

Alnylam Pharmaceuticals

Yoshitaka Nemoto

Vice President R&D

PeptiStar

Judith Newmark, PhD

Associate Director of Pharmacology and Toxicology

Editas Medicine

Jan Nickolaus, PhD

Head of Quality Control

BioSpring GmbH

Mehran Nikan, PhD

Research Fellow

Ionis Pharmaceuticals

Karyn O'Neil, PhD

Chief Scientific Officer

Ar­o Biotherapeutics

Rubina Parmar, PhD

Vice President, Chemistry and Delivery Sciences

Intellia Therapeutics

Tao Pei, PhD

Senior Vice President, Chemistry

Arrowhead Pharmaceuticals

David Pekker, PhD

Senior Director, Theory

Creyon Bio

Bradley Pentelute, PhD

Professor, Chemistry

Massachusetts Institute of Technology

Gerard Platenburg, PhD

Chief Scientific Officer

ProQR Therapeutics

James Powell

SVP, Manufacturing

Dicerna Pharmaceuticals

Anna Puszkarska, PhD

Machine Learning Lead

Sanofi

Leo Qian, PhD

Co-Founder and Vice President, Discovery Research

Entrada Therapeutics

Matthew Quinn

Manager, Analytical Development, Global Nucleic Acid Therapies

Novo Nordisk

Anusha Regupathy

Senior Scientist, Medicinal Chemistry

Bicycle Therapeutics

El Djouhar Rekaï, PhD

Head of Peptide Process Development & Manufacturing

PolyPeptide Group

Claus Rentel, PhD

Vice President, Analytical Development/QC

Ionis Pharmaceuticals, Inc.

Syed Reza, MD, PhD

Scientific and Sales Consultant

NOF Corporation

Francis Ring

Director of Manufacturing & Operations

Ionis Pharmaceuticals

Thomas Rupp

Managing Director

Axolabs Berlin GmbH

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Dr. Daniel Santi, MD, PhD

President and Co-founder

ProLynx LLC

Sriram Sathy, Ph.D.

Chief Scientific Officer

AIRNA

Alfica Sehgal, PhD

Chief Scientific Officer

Judo Bio

Dr Cole Seifert, PhD

Research & Technology Specialist

Croda Inc.

Anna Senczuk

Senior Director, mRNA Process Development

CSL Seqirus

Punit Seth, PhD

SVP, Research

Alnylam Pharmaceuticals

Trishul Shah, M.S.

Global Sales and Marketing (interim), Head of Sales, Americas

PolyPeptide Laboratories Inc.

Jagesh Shah, PhD

Senior Vice President, Head of Platform

Mirai Bio

Chikdu Shivalila, PhD

Senior Director of Platform Biology

Wave Life Sciences

Sirat Sikka

Senior Scientist, Applications and Innovation

Thermo Fisher Scientific

Manmohan Singh, PhD

Chief Technology Officer

Beam Therapeutics

Stephen Spagnol, PhD

Director, Enabling Technologies

Merck

G. Susan Srivatsa, PhD

President

ElixinPharma

Hiroaki Suga, PhD

Professor of Chemistry, School of Science

University of Tokyo

Ying Tam, PhD

Chief Scientific Officer

Acuitas Therapeutics

Ali Tavassoli, Ph.D.

CSO, Curve Therapeutics

University of Southampton

René Thürmer, PhD

Deputy Head

BfArM Federal Institute for Drugs & Medical Devices

Barry Ticho

Chief Medical Officer

Stoke Therapeutics

Dr. Peter Timmerman, PhD

Head of Peptide Science

Biosynth

Sho Toyonaga

Director, Drug Delivery Research

FUJIFILM Pharmaceuticals U.S.A., Inc

Sam Tsimikas, MD

Senior Vice President of Global Cardiovascular Development

Ionis Pharmaceuticals

Kurt Vagle

Senior Director - Chemical Development RNAi CMC

Novo Nordisk

Sonia Vallabh, PhD

Director, Prion Therapeutic Science

Broad Institute of MIT & Harvard

Leendert van den Bos

Chief Executive Officer

EnzyTag BV

Chandra Vargeese, PhD

Chief Technology Officer

Wave Life Science

Kalin Vetsigian, PhD

Senior Director, AI & Machine Learning

GSK

Matteo Villain, PhD

Vice President and Global Peptides Technical Lead

Piramal Pharma Solutions

Thomas Vrucina

Deputy Head Liposome Technology

Polymun Scientific

Liron Walsh, M.D.

Vice President and Head of Development, In Vivo Programs

Intellia Therapeutics

Yen-Chih Wang, PhD

Assistant Director, Analytical Development and Quality Control

Ionis Pharmaceuticals

Sven Warhaut, PhD

Vice Head of Manufacturing

BioSpring

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Fran Wincott, PhD

President

Wincott & Associates, LLC

Dr. Steven Wolk, PhD

President

Siniwali Biotechnology Solutions

Kristy Wood, PhD

SVP, Technical Operations

Intellia Therapeutics

Paul Wrighton, PhD

Senior Scientist II, In Vivo Gene Editing

Editas Medicine

Chunping Xu, Ph.D

Senior Director of Chemistry R&D

TriLink BioTechnologies

Dr. Chun Yang, PhD

Senior Director of Biology

Nitto BioPharma

Ed Yaworski

Chief Technology Officer

Genevant Sciences Corp

Dr. Stefano Zanotti, PhD

Head of Neuromuscular Research

Dyne Therapeutics

Xuan Zhou

Associate Director, ASO Process Chemistry Lead

Biogen

Helge Zieler, PhD

CEO

Primrose Bio

Dr. John Zuris, PhD

Director of Delivery and Editing Technologies

Editas Medicine